Bibliographic Details
| Title: |
Clinical evidences of GM3 (NeuGc) ganglioside expression in human breast cancer using the 14F7 monoclonal antibody labelled with (99m)Tc. |
| Authors: |
Oliva JP; Department of Nuclear Medicine, National Institute of Oncology and Radiobiology, Plaza, Havana, Cuba., Valdés Z, Casacó A, Pimentel G, González J, Alvarez I, Osorio M, Velazco M, Figueroa M, Ortiz R, Escobar X, Orozco M, Cruz J, Franco S, Díaz M, Roque L, Carr A, Vázquez AM, Mateos C, Rubio MC, Pérez R, Fernández LE |
| Source: |
Breast cancer research and treatment [Breast Cancer Res Treat] 2006 Mar; Vol. 96 (2), pp. 115-21. Date of Electronic Publication: 2005 Dec 02. |
| Publication Type: |
Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article |
| Journal Info: |
Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Print ISSN: 0167-6806 (Print) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE |
| Database: |
MEDLINE Ultimate |
